BeiGene to Invest Hundreds of Millions of Dollars in US Manufacturing Site
publication date: Nov 24, 2021
Beijing's BeiGene closed on a 42-acre US site in the Princeton, NJ area where it will build a manufacturing center and house clinical R&D operations. The company said it would invest hundreds of millions of dollars to build a state-of-the art 400,000 square feet biologic manufacturing facility. In its first phase, the plant will include up to 16,000 liters of biologics capacity, along with clinical R&D and office space. The site has more than one million square feet of space for additional facilities as needed. More details....
Stock Symbols: (NSDQ: BGNE; HK: 06160)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.